Our previous studies also found that EGCG, as well as EC, ECG, and EGC, may bind to some cancer‐related proteins in TPK‐RAS‐MAPK and NF‐κB signaling pathways when used molecular docking of these bioactive substances (Zheng, Chen, & Lu, 2011). Here, NFKB1 is linked to cancer.